CAR T Cells from Code to Clinic: Framing Modeling Approaches with Current Translational Research Goals

Lucas E Sant'Anna, Rohita Roy, Janella C Schwab +2

Chimeric Antigen Receptor (CAR) T cell therapy has transformed immunotherapy for resistant cancers, yet it faces major limitations such as lack of persistence, toxicity, exhaustion…